InsidersTradesSigma
Follow the PORTOLA PHARMACEUTICALS INC stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). The latest transaction was disclosed on 29 January 2016 (Attribution). Among the most active insiders: Curnutte John T. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Portola Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for thromboembolic diseases. It is listed on NASDAQ under the ticker PTLA.